ZA858237B - Ing 1-b-d-ribofuranosyl-1,2,4-triazole-3-carboxamine method of medical treatment of human viral diseases utiliz - Google Patents

Ing 1-b-d-ribofuranosyl-1,2,4-triazole-3-carboxamine method of medical treatment of human viral diseases utiliz

Info

Publication number
ZA858237B
ZA858237B ZA858237A ZA858237A ZA858237B ZA 858237 B ZA858237 B ZA 858237B ZA 858237 A ZA858237 A ZA 858237A ZA 858237 A ZA858237 A ZA 858237A ZA 858237 B ZA858237 B ZA 858237B
Authority
ZA
South Africa
Prior art keywords
ribofuranosyl
triazole
medical treatment
viral diseases
carboxamine
Prior art date
Application number
ZA858237A
Other languages
English (en)
Original Assignee
Vira Tek Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24673430&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA858237(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Vira Tek Inc filed Critical Vira Tek Inc
Publication of ZA858237B publication Critical patent/ZA858237B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/056—Triazole or tetrazole radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
ZA858237A 1984-10-29 1985-10-28 Ing 1-b-d-ribofuranosyl-1,2,4-triazole-3-carboxamine method of medical treatment of human viral diseases utiliz ZA858237B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US66625284A 1984-10-29 1984-10-29

Publications (1)

Publication Number Publication Date
ZA858237B true ZA858237B (en) 1988-02-24

Family

ID=24673430

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA858237A ZA858237B (en) 1984-10-29 1985-10-28 Ing 1-b-d-ribofuranosyl-1,2,4-triazole-3-carboxamine method of medical treatment of human viral diseases utiliz

Country Status (19)

Country Link
EP (3) EP0181050A3 (xx)
JP (1) JPH0713019B2 (xx)
KR (1) KR860003018A (xx)
AT (1) ATE204173T1 (xx)
AU (1) AU584333B2 (xx)
BE (1) BE902199A (xx)
CA (1) CA1261265A (xx)
DD (1) DD261094A5 (xx)
DE (3) DE10299005I2 (xx)
ES (1) ES8704962A1 (xx)
FR (1) FR2572286B1 (xx)
GB (1) GB2166050B (xx)
HK (1) HK1010985A1 (xx)
LU (1) LU85854A1 (xx)
NL (1) NL300083I1 (xx)
NZ (1) NZ212510A (xx)
PH (1) PH22534A (xx)
PT (1) PT81387B (xx)
ZA (1) ZA858237B (xx)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0252962B1 (en) * 1985-12-23 1995-08-23 Fred Hutchinson Cancer Research Center Regulating retroviral replication, infection, and pathogenesis
JP2792246B2 (ja) * 1991-01-31 1998-09-03 信越半導体株式会社 単結晶棒クランプ位置決め治具及びこれを用いた単結晶棒クランプ位置決め方法
MXPA01007211A (es) * 1999-01-29 2002-05-06 Icn Pharmaceuticals Modulacion de la respuesta inmune por ribavirina.
US6720000B2 (en) 2001-03-19 2004-04-13 Three Rivers Pharmaceutical, Llc Process for producing wet ribavirin pellets
US7132453B2 (en) * 2002-03-15 2006-11-07 Vanderbilt University Method of using prostacyclin to treat respiratory syncytial virus infections
US7538094B2 (en) 2002-09-19 2009-05-26 Three Rivers Pharmacueticals, Llc Composition containing ribavirin and use thereof
EA201692515A1 (ru) 2014-06-23 2017-05-31 Сановель Илач Санайи Ве Тиджарет А.Ш. Новая фармацевтическая композиция на основе софосбувира и рибавирина
EA201692514A1 (ru) 2014-06-23 2017-04-28 Сановель Илач Санайи Ве Тиджарет А.Ш. Фармацевтические композиции на основе софосбувира и рибавирина с модифицированным высвобождением
EP2959901A1 (en) 2014-06-23 2015-12-30 Sanovel Ilac Sanayi ve Ticaret A.S. Pharmaceutical combinations of sofosbuvir and ribavirin

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3927216A (en) * 1971-06-01 1975-12-16 Icn Pharmaceuticals 1,2,4-Triazol E-3-carboxamides for inhibiting virus infections
US4211771A (en) * 1971-06-01 1980-07-08 Robins Ronald K Treatment of human viral diseases with 1-B-D-ribofuranosyl-1,2,4-triazole-3-carboxamide
US3798209A (en) * 1971-06-01 1974-03-19 Icn Pharmaceuticals 1,2,4-triazole nucleosides
AR205339A1 (es) * 1973-03-12 1976-04-30 Icn Pharmaceuticals Sintesis de 1,2,4-triazolo-3-carboxamidas utiles como agentes antivirales
AU564876B2 (en) * 1982-03-29 1987-08-27 Liposome Company, Inc., The Stable plurilamellar vesicles

Also Published As

Publication number Publication date
ES8704962A1 (es) 1987-04-16
HK1010985A1 (en) 1999-07-02
JPH0713019B2 (ja) 1995-02-15
JPS61109723A (ja) 1986-05-28
EP0643970A3 (en) 1997-07-09
DE3588232D1 (de) 2001-09-20
EP0643970B1 (en) 2001-08-16
AU584333B2 (en) 1989-05-25
EP0383361A3 (en) 1993-06-16
DD261094A5 (de) 1988-10-19
EP0383361A2 (en) 1990-08-22
PT81387A (en) 1985-11-01
EP0181050A3 (en) 1987-10-21
GB2166050A (en) 1986-04-30
CA1261265A (en) 1989-09-26
BE902199A (fr) 1985-07-31
ATE204173T1 (de) 2001-09-15
ES548303A0 (es) 1987-04-16
DE10299005I1 (de) 2002-05-08
EP0643970A2 (en) 1995-03-22
DE181050T1 (de) 1986-12-18
GB2166050B (en) 1989-08-16
FR2572286B1 (fr) 1990-03-23
DE10299005I2 (de) 2004-07-01
EP0181050A2 (en) 1986-05-14
LU85854A1 (fr) 1985-12-16
KR860003018A (ko) 1986-05-19
NZ212510A (en) 1989-04-26
FR2572286A1 (fr) 1986-05-02
DE3588232T2 (de) 2002-06-13
GB8509689D0 (en) 1985-05-22
NL300083I1 (nl) 2002-05-01
PT81387B (pt) 1987-11-11
AU4180785A (en) 1986-05-08
PH22534A (en) 1988-10-17

Similar Documents

Publication Publication Date Title
DE3579113D1 (de) Zusammensetzungen zur milderung, behandlung und bestimmungung von arthritschen krankheiten und aehnlichen zustaenden.
BR9714363A (pt) Derivados de pirazol substituìdos para o tratamento de doenças circulatórias cardìacas
MY130035A (en) Antiviral compounds
UA39158C2 (uk) Похідні n4-оксикарбоніл-5'-дезокси-5-фторцитидину та фармацевтичний препарат на їх основі
EP0151989A3 (en) Means for the treatment of cardiac diseases
ZA858237B (en) Ing 1-b-d-ribofuranosyl-1,2,4-triazole-3-carboxamine method of medical treatment of human viral diseases utiliz
DE3462688D1 (en) 1,7-diphenyl-3-methylaza-7-cyano-8-methylnonane useful in combating diseases
DE3585643D1 (de) Antiviren-verbindungen, behandlung und formulierungen.
DE3378979D1 (en) 1-acyl-3-pyridylmethylguanidines and their use as antihypertensive agents
AU616657B2 (en) Butyl hydroxyanisoles for the treatment of retroviral diseases
MD1051C2 (ro) Remediu antiherpetic
NO993997D0 (no) Anvendelse av 9,10-sekokolesta-5,7,10(19)-trien-1-3-diol, eller alfakalsidol
AU1162788A (en) Oxime-ethers of 2,6-dioxobicyclo-(3.3.0)octanones for treatment of heart and circulation diseases
IT8522576A0 (it) Composizione farmaceutica per il trattamento di disturbi respiratori, muscolari e articolari.
UA23352A (uk) beta- D- ГЛЮКОЗАМОHІЙHА СІЛЬ alРha-БРОМІЗОВАЛЕРІАHОВОЇ КИСЛОТИ, ЯКА МАЄ ПРОТИВІРУСHУ АКТИВHІСТЬ ВІДHОСHО ВІРУСУ ВЕЗИКУЛЯРHОГО СТОМАТИТУ, ВІРУСУ ПРОСТОГО ГЕРПЕСУ ТА КОРОHАВІРУСУ
ATE81587T1 (de) Medizinisches praeparat zur behandlung von hautleiden.
ATE74767T1 (de) Arzneimittelzusammensetzung zur behandlung des lungenverstopfens.
IS3304A7 (is) Aðferð til framleiðslu, notkun og samsetning efnablöndu til meðhöndlunar sóriasis, gigtar eða andarteppusjúkdóma.